nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—ALB—Acitretin—psoriasis	0.0821	0.116	CbGbCtD
Fosphenytoin—CYP2C8—Tazarotene—psoriasis	0.0803	0.113	CbGbCtD
Fosphenytoin—CYP2B6—Cholecalciferol—psoriasis	0.0452	0.0639	CbGbCtD
Fosphenytoin—ALB—Mycophenolate mofetil—psoriasis	0.0384	0.0543	CbGbCtD
Fosphenytoin—CYP2C8—Cholecalciferol—psoriasis	0.0343	0.0484	CbGbCtD
Fosphenytoin—ALB—Prednisone—psoriasis	0.0307	0.0434	CbGbCtD
Fosphenytoin—CYP2C8—Mycophenolate mofetil—psoriasis	0.0297	0.042	CbGbCtD
Fosphenytoin—CYP2C19—Cholecalciferol—psoriasis	0.0287	0.0406	CbGbCtD
Fosphenytoin—CYP3A4—Calcitriol—psoriasis	0.027	0.0381	CbGbCtD
Fosphenytoin—CYP2C9—Cholecalciferol—psoriasis	0.0239	0.0338	CbGbCtD
Fosphenytoin—CYP2C8—Hydrocortisone—psoriasis	0.0238	0.0337	CbGbCtD
Fosphenytoin—CYP2C8—Cyclosporine—psoriasis	0.0225	0.0318	CbGbCtD
Fosphenytoin—CYP3A4—Methoxsalen—psoriasis	0.021	0.0296	CbGbCtD
Fosphenytoin—CYP2C19—Prednisone—psoriasis	0.0199	0.0281	CbGbCtD
Fosphenytoin—CYP2B6—Dexamethasone—psoriasis	0.0196	0.0276	CbGbCtD
Fosphenytoin—CYP2C19—Cyclosporine—psoriasis	0.0189	0.0267	CbGbCtD
Fosphenytoin—CYP2C9—Cyclosporine—psoriasis	0.0157	0.0222	CbGbCtD
Fosphenytoin—ALB—Methotrexate—psoriasis	0.0154	0.0218	CbGbCtD
Fosphenytoin—CYP2C8—Dexamethasone—psoriasis	0.0148	0.0209	CbGbCtD
Fosphenytoin—CYP3A4—Cholecalciferol—psoriasis	0.0139	0.0196	CbGbCtD
Fosphenytoin—CYP2C19—Dexamethasone—psoriasis	0.0124	0.0176	CbGbCtD
Fosphenytoin—CYP3A4—Triamcinolone—psoriasis	0.012	0.017	CbGbCtD
Fosphenytoin—CYP3A4—Mycophenolate mofetil—psoriasis	0.012	0.017	CbGbCtD
Fosphenytoin—CYP2C9—Dexamethasone—psoriasis	0.0103	0.0146	CbGbCtD
Fosphenytoin—CYP3A4—Betamethasone—psoriasis	0.0103	0.0146	CbGbCtD
Fosphenytoin—CYP3A4—Prednisolone—psoriasis	0.0102	0.0144	CbGbCtD
Fosphenytoin—CYP3A4—Hydrocortisone—psoriasis	0.00967	0.0137	CbGbCtD
Fosphenytoin—CYP3A4—Prednisone—psoriasis	0.00963	0.0136	CbGbCtD
Fosphenytoin—CYP3A4—Cyclosporine—psoriasis	0.00913	0.0129	CbGbCtD
Fosphenytoin—CYP3A4—Dexamethasone—psoriasis	0.00601	0.00849	CbGbCtD
Fosphenytoin—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.00143	0.0802	CbGpPWpGaD
Fosphenytoin—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00121	0.0679	CbGpPWpGaD
Fosphenytoin—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00108	0.0606	CbGpPWpGaD
Fosphenytoin—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.000985	0.0553	CbGpPWpGaD
Fosphenytoin—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.000887	0.0497	CbGpPWpGaD
Fosphenytoin—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.000751	0.0421	CbGpPWpGaD
Fosphenytoin—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00067	0.0376	CbGpPWpGaD
Fosphenytoin—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000611	0.0343	CbGpPWpGaD
Fosphenytoin—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000403	0.0226	CbGpPWpGaD
Fosphenytoin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000368	0.0206	CbGpPWpGaD
Fosphenytoin—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000363	0.0204	CbGpPWpGaD
Fosphenytoin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000312	0.0175	CbGpPWpGaD
Fosphenytoin—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000308	0.0173	CbGpPWpGaD
Fosphenytoin—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000298	0.0167	CbGpPWpGaD
Fosphenytoin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000278	0.0156	CbGpPWpGaD
Fosphenytoin—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000275	0.0154	CbGpPWpGaD
Fosphenytoin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000254	0.0142	CbGpPWpGaD
Fosphenytoin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000253	0.0142	CbGpPWpGaD
Fosphenytoin—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00025	0.014	CbGpPWpGaD
Fosphenytoin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000226	0.0126	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.00022	0.0123	CbGpPWpGaD
Fosphenytoin—ALB—HDL-mediated lipid transport—APOE—psoriasis	0.000219	0.0123	CbGpPWpGaD
Fosphenytoin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000206	0.0115	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—IL13—psoriasis	0.000173	0.00973	CbGpPWpGaD
Fosphenytoin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000169	0.00949	CbGpPWpGaD
Fosphenytoin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000167	0.00938	CbGpPWpGaD
Fosphenytoin—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000165	0.00926	CbGpPWpGaD
Fosphenytoin—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000159	0.00889	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000156	0.00877	CbGpPWpGaD
Fosphenytoin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000136	0.00761	CbGpPWpGaD
Fosphenytoin—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000134	0.00753	CbGpPWpGaD
Fosphenytoin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000134	0.0075	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000132	0.00742	CbGpPWpGaD
Fosphenytoin—ALB—Lipoprotein metabolism—APOE—psoriasis	0.000126	0.00706	CbGpPWpGaD
Fosphenytoin—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.00012	0.00672	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000118	0.00663	CbGpPWpGaD
Fosphenytoin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000118	0.00661	CbGpPWpGaD
Fosphenytoin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000117	0.00654	CbGpPWpGaD
Fosphenytoin—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000116	0.00652	CbGpPWpGaD
Fosphenytoin—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000109	0.00613	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—IL10—psoriasis	0.000109	0.00609	CbGpPWpGaD
Fosphenytoin—Infection—Hydrocortisone—psoriasis	0.000108	0.000395	CcSEcCtD
Fosphenytoin—Insomnia—Mycophenolate mofetil—psoriasis	0.000108	0.000394	CcSEcCtD
Fosphenytoin—Dyspepsia—Cyclosporine—psoriasis	0.000108	0.000394	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Prednisolone—psoriasis	0.000108	0.000393	CcSEcCtD
Fosphenytoin—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000108	0.00604	CbGpPWpGaD
Fosphenytoin—Nausea—Hydroxyurea—psoriasis	0.000107	0.000392	CcSEcCtD
Fosphenytoin—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000107	0.000392	CcSEcCtD
Fosphenytoin—Pruritus—Mycophenolic acid—psoriasis	0.000107	0.000391	CcSEcCtD
Fosphenytoin—Shock—Hydrocortisone—psoriasis	0.000107	0.000391	CcSEcCtD
Fosphenytoin—Myalgia—Triamcinolone—psoriasis	0.000107	0.00039	CcSEcCtD
Fosphenytoin—Pneumonia—Methotrexate—psoriasis	0.000107	0.00039	CcSEcCtD
Fosphenytoin—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000107	0.000389	CcSEcCtD
Fosphenytoin—Decreased appetite—Cyclosporine—psoriasis	0.000107	0.000389	CcSEcCtD
Fosphenytoin—Tachycardia—Hydrocortisone—psoriasis	0.000106	0.000388	CcSEcCtD
Fosphenytoin—Somnolence—Mycophenolate mofetil—psoriasis	0.000106	0.000388	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Dexamethasone—psoriasis	0.000106	0.000386	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Betamethasone—psoriasis	0.000106	0.000386	CcSEcCtD
Fosphenytoin—Discomfort—Triamcinolone—psoriasis	0.000106	0.000386	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Hydrocortisone—psoriasis	0.000105	0.000384	CcSEcCtD
Fosphenytoin—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000105	0.000384	CcSEcCtD
Fosphenytoin—Constipation—Cyclosporine—psoriasis	0.000105	0.000382	CcSEcCtD
Fosphenytoin—Dry mouth—Triamcinolone—psoriasis	0.000105	0.000382	CcSEcCtD
Fosphenytoin—Renal failure—Methotrexate—psoriasis	0.000104	0.000381	CcSEcCtD
Fosphenytoin—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000104	0.000379	CcSEcCtD
Fosphenytoin—Anorexia—Hydrocortisone—psoriasis	0.000104	0.000379	CcSEcCtD
Fosphenytoin—Diarrhoea—Mycophenolic acid—psoriasis	0.000104	0.000378	CcSEcCtD
Fosphenytoin—Conjunctivitis—Methotrexate—psoriasis	0.000103	0.000377	CcSEcCtD
Fosphenytoin—Malaise—Betamethasone—psoriasis	0.000103	0.000375	CcSEcCtD
Fosphenytoin—Malaise—Dexamethasone—psoriasis	0.000103	0.000375	CcSEcCtD
Fosphenytoin—ALB—Hemostasis—SERPINB8—psoriasis	0.000103	0.00576	CbGpPWpGaD
Fosphenytoin—Anaphylactic shock—Triamcinolone—psoriasis	0.000103	0.000374	CcSEcCtD
Fosphenytoin—Vertigo—Betamethasone—psoriasis	0.000102	0.000374	CcSEcCtD
Fosphenytoin—Vertigo—Dexamethasone—psoriasis	0.000102	0.000374	CcSEcCtD
Fosphenytoin—Syncope—Betamethasone—psoriasis	0.000102	0.000373	CcSEcCtD
Fosphenytoin—Syncope—Dexamethasone—psoriasis	0.000102	0.000373	CcSEcCtD
Fosphenytoin—Constipation—Mycophenolate mofetil—psoriasis	0.000102	0.000373	CcSEcCtD
Fosphenytoin—Infection—Triamcinolone—psoriasis	0.000102	0.000372	CcSEcCtD
Fosphenytoin—Sweating—Methotrexate—psoriasis	0.000102	0.000371	CcSEcCtD
Fosphenytoin—Hypotension—Hydrocortisone—psoriasis	0.000102	0.000371	CcSEcCtD
Fosphenytoin—Feeling abnormal—Cyclosporine—psoriasis	0.000101	0.000368	CcSEcCtD
Fosphenytoin—Shock—Triamcinolone—psoriasis	0.000101	0.000368	CcSEcCtD
Fosphenytoin—Insomnia—Prednisolone—psoriasis	0.000101	0.000368	CcSEcCtD
Fosphenytoin—Loss of consciousness—Dexamethasone—psoriasis	0.0001	0.000366	CcSEcCtD
Fosphenytoin—Loss of consciousness—Betamethasone—psoriasis	0.0001	0.000366	CcSEcCtD
Fosphenytoin—Dizziness—Mycophenolic acid—psoriasis	0.0001	0.000365	CcSEcCtD
Fosphenytoin—Epistaxis—Methotrexate—psoriasis	0.0001	0.000365	CcSEcCtD
Fosphenytoin—Paraesthesia—Prednisolone—psoriasis	0.0001	0.000365	CcSEcCtD
Fosphenytoin—Tachycardia—Triamcinolone—psoriasis	0.0001	0.000365	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	9.92e-05	0.000362	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Triamcinolone—psoriasis	9.92e-05	0.000362	CcSEcCtD
Fosphenytoin—Convulsion—Dexamethasone—psoriasis	9.88e-05	0.00036	CcSEcCtD
Fosphenytoin—Convulsion—Betamethasone—psoriasis	9.88e-05	0.00036	CcSEcCtD
Fosphenytoin—Feeling abnormal—Mycophenolate mofetil—psoriasis	9.85e-05	0.000359	CcSEcCtD
Fosphenytoin—Insomnia—Hydrocortisone—psoriasis	9.85e-05	0.000359	CcSEcCtD
Fosphenytoin—Hypertension—Dexamethasone—psoriasis	9.85e-05	0.000359	CcSEcCtD
Fosphenytoin—Hypertension—Betamethasone—psoriasis	9.85e-05	0.000359	CcSEcCtD
Fosphenytoin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	9.81e-05	0.0055	CbGpPWpGaD
Fosphenytoin—Paraesthesia—Hydrocortisone—psoriasis	9.78e-05	0.000357	CcSEcCtD
Fosphenytoin—Urticaria—Cyclosporine—psoriasis	9.74e-05	0.000355	CcSEcCtD
Fosphenytoin—Myalgia—Dexamethasone—psoriasis	9.71e-05	0.000354	CcSEcCtD
Fosphenytoin—Myalgia—Betamethasone—psoriasis	9.71e-05	0.000354	CcSEcCtD
Fosphenytoin—Body temperature increased—Cyclosporine—psoriasis	9.69e-05	0.000353	CcSEcCtD
Fosphenytoin—Vomiting—Mycophenolic acid—psoriasis	9.63e-05	0.000351	CcSEcCtD
Fosphenytoin—Discomfort—Betamethasone—psoriasis	9.59e-05	0.00035	CcSEcCtD
Fosphenytoin—Discomfort—Dexamethasone—psoriasis	9.59e-05	0.00035	CcSEcCtD
Fosphenytoin—Dyspepsia—Hydrocortisone—psoriasis	9.59e-05	0.00035	CcSEcCtD
Fosphenytoin—Rash—Mycophenolic acid—psoriasis	9.55e-05	0.000348	CcSEcCtD
Fosphenytoin—Dermatitis—Mycophenolic acid—psoriasis	9.54e-05	0.000348	CcSEcCtD
Fosphenytoin—Urticaria—Mycophenolate mofetil—psoriasis	9.5e-05	0.000346	CcSEcCtD
Fosphenytoin—Headache—Mycophenolic acid—psoriasis	9.49e-05	0.000346	CcSEcCtD
Fosphenytoin—Decreased appetite—Hydrocortisone—psoriasis	9.47e-05	0.000345	CcSEcCtD
Fosphenytoin—Pharyngitis—Methotrexate—psoriasis	9.46e-05	0.000345	CcSEcCtD
Fosphenytoin—Body temperature increased—Mycophenolate mofetil—psoriasis	9.45e-05	0.000345	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Triamcinolone—psoriasis	9.35e-05	0.000341	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Betamethasone—psoriasis	9.31e-05	0.000339	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Dexamethasone—psoriasis	9.31e-05	0.000339	CcSEcCtD
Fosphenytoin—Insomnia—Triamcinolone—psoriasis	9.28e-05	0.000338	CcSEcCtD
Fosphenytoin—Infection—Dexamethasone—psoriasis	9.25e-05	0.000337	CcSEcCtD
Fosphenytoin—Infection—Betamethasone—psoriasis	9.25e-05	0.000337	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Prednisone—psoriasis	9.21e-05	0.000336	CcSEcCtD
Fosphenytoin—Paraesthesia—Triamcinolone—psoriasis	9.21e-05	0.000336	CcSEcCtD
Fosphenytoin—Feeling abnormal—Prednisolone—psoriasis	9.19e-05	0.000335	CcSEcCtD
Fosphenytoin—Anaemia—Prednisone—psoriasis	9.18e-05	0.000335	CcSEcCtD
Fosphenytoin—Shock—Betamethasone—psoriasis	9.16e-05	0.000334	CcSEcCtD
Fosphenytoin—Shock—Dexamethasone—psoriasis	9.16e-05	0.000334	CcSEcCtD
Fosphenytoin—Dyspnoea—Triamcinolone—psoriasis	9.14e-05	0.000334	CcSEcCtD
Fosphenytoin—Agitation—Prednisone—psoriasis	9.13e-05	0.000333	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Dexamethasone—psoriasis	9.11e-05	0.000332	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Betamethasone—psoriasis	9.11e-05	0.000332	CcSEcCtD
Fosphenytoin—Tachycardia—Betamethasone—psoriasis	9.08e-05	0.000331	CcSEcCtD
Fosphenytoin—Tachycardia—Dexamethasone—psoriasis	9.08e-05	0.000331	CcSEcCtD
Fosphenytoin—Dyspepsia—Triamcinolone—psoriasis	9.03e-05	0.000329	CcSEcCtD
Fosphenytoin—Nausea—Mycophenolic acid—psoriasis	9e-05	0.000328	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Betamethasone—psoriasis	9e-05	0.000328	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Dexamethasone—psoriasis	9e-05	0.000328	CcSEcCtD
Fosphenytoin—Feeling abnormal—Hydrocortisone—psoriasis	8.98e-05	0.000327	CcSEcCtD
Fosphenytoin—Malaise—Prednisone—psoriasis	8.96e-05	0.000327	CcSEcCtD
Fosphenytoin—Vertigo—Prednisone—psoriasis	8.92e-05	0.000325	CcSEcCtD
Fosphenytoin—Syncope—Prednisone—psoriasis	8.91e-05	0.000325	CcSEcCtD
Fosphenytoin—Tinnitus—Methotrexate—psoriasis	8.89e-05	0.000324	CcSEcCtD
Fosphenytoin—Anorexia—Betamethasone—psoriasis	8.87e-05	0.000324	CcSEcCtD
Fosphenytoin—Anorexia—Dexamethasone—psoriasis	8.87e-05	0.000324	CcSEcCtD
Fosphenytoin—Urticaria—Prednisolone—psoriasis	8.86e-05	0.000323	CcSEcCtD
Fosphenytoin—Asthenia—Cyclosporine—psoriasis	8.79e-05	0.000321	CcSEcCtD
Fosphenytoin—Loss of consciousness—Prednisone—psoriasis	8.73e-05	0.000318	CcSEcCtD
Fosphenytoin—Hypotension—Dexamethasone—psoriasis	8.7e-05	0.000317	CcSEcCtD
Fosphenytoin—Hypotension—Betamethasone—psoriasis	8.7e-05	0.000317	CcSEcCtD
Fosphenytoin—Pruritus—Cyclosporine—psoriasis	8.67e-05	0.000316	CcSEcCtD
Fosphenytoin—Urticaria—Hydrocortisone—psoriasis	8.65e-05	0.000316	CcSEcCtD
Fosphenytoin—ALB—Folate Metabolism—CAT—psoriasis	8.62e-05	0.00484	CbGpPWpGaD
Fosphenytoin—Body temperature increased—Hydrocortisone—psoriasis	8.61e-05	0.000314	CcSEcCtD
Fosphenytoin—Convulsion—Prednisone—psoriasis	8.6e-05	0.000314	CcSEcCtD
Fosphenytoin—Asthenia—Mycophenolate mofetil—psoriasis	8.58e-05	0.000313	CcSEcCtD
Fosphenytoin—Hypertension—Prednisone—psoriasis	8.57e-05	0.000313	CcSEcCtD
Fosphenytoin—Chills—Methotrexate—psoriasis	8.55e-05	0.000312	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Dexamethasone—psoriasis	8.48e-05	0.000309	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Betamethasone—psoriasis	8.48e-05	0.000309	CcSEcCtD
Fosphenytoin—Pruritus—Mycophenolate mofetil—psoriasis	8.46e-05	0.000309	CcSEcCtD
Fosphenytoin—Myalgia—Prednisone—psoriasis	8.45e-05	0.000308	CcSEcCtD
Fosphenytoin—Arthralgia—Prednisone—psoriasis	8.45e-05	0.000308	CcSEcCtD
Fosphenytoin—Feeling abnormal—Triamcinolone—psoriasis	8.45e-05	0.000308	CcSEcCtD
Fosphenytoin—Insomnia—Dexamethasone—psoriasis	8.42e-05	0.000307	CcSEcCtD
Fosphenytoin—Insomnia—Betamethasone—psoriasis	8.42e-05	0.000307	CcSEcCtD
Fosphenytoin—ALB—Vitamin B12 Metabolism—CRP—psoriasis	8.42e-05	0.00472	CbGpPWpGaD
Fosphenytoin—Diarrhoea—Cyclosporine—psoriasis	8.39e-05	0.000306	CcSEcCtD
Fosphenytoin—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	8.37e-05	0.00469	CbGpPWpGaD
Fosphenytoin—Paraesthesia—Dexamethasone—psoriasis	8.36e-05	0.000305	CcSEcCtD
Fosphenytoin—Paraesthesia—Betamethasone—psoriasis	8.36e-05	0.000305	CcSEcCtD
Fosphenytoin—Discomfort—Prednisone—psoriasis	8.35e-05	0.000305	CcSEcCtD
Fosphenytoin—ALB—Vitamin B12 Metabolism—APOE—psoriasis	8.24e-05	0.00462	CbGpPWpGaD
Fosphenytoin—Dyspepsia—Betamethasone—psoriasis	8.19e-05	0.000299	CcSEcCtD
Fosphenytoin—Dyspepsia—Dexamethasone—psoriasis	8.19e-05	0.000299	CcSEcCtD
Fosphenytoin—Diarrhoea—Mycophenolate mofetil—psoriasis	8.18e-05	0.000298	CcSEcCtD
Fosphenytoin—Urticaria—Triamcinolone—psoriasis	8.15e-05	0.000297	CcSEcCtD
Fosphenytoin—Dysgeusia—Methotrexate—psoriasis	8.13e-05	0.000296	CcSEcCtD
Fosphenytoin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.12e-05	0.00456	CbGpPWpGaD
Fosphenytoin—Body temperature increased—Triamcinolone—psoriasis	8.11e-05	0.000296	CcSEcCtD
Fosphenytoin—Dizziness—Cyclosporine—psoriasis	8.11e-05	0.000296	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Prednisone—psoriasis	8.11e-05	0.000296	CcSEcCtD
Fosphenytoin—Decreased appetite—Dexamethasone—psoriasis	8.09e-05	0.000295	CcSEcCtD
Fosphenytoin—Decreased appetite—Betamethasone—psoriasis	8.09e-05	0.000295	CcSEcCtD
Fosphenytoin—Infection—Prednisone—psoriasis	8.05e-05	0.000294	CcSEcCtD
Fosphenytoin—Back pain—Methotrexate—psoriasis	8.03e-05	0.000293	CcSEcCtD
Fosphenytoin—Shock—Prednisone—psoriasis	7.97e-05	0.000291	CcSEcCtD
Fosphenytoin—ALB—Folate Metabolism—IL4—psoriasis	7.92e-05	0.00444	CbGpPWpGaD
Fosphenytoin—Tachycardia—Prednisone—psoriasis	7.91e-05	0.000289	CcSEcCtD
Fosphenytoin—Dizziness—Mycophenolate mofetil—psoriasis	7.91e-05	0.000288	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Prednisone—psoriasis	7.84e-05	0.000286	CcSEcCtD
Fosphenytoin—Asthenia—Hydrocortisone—psoriasis	7.82e-05	0.000285	CcSEcCtD
Fosphenytoin—Vomiting—Cyclosporine—psoriasis	7.79e-05	0.000284	CcSEcCtD
Fosphenytoin—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	7.74e-05	0.00434	CbGpPWpGaD
Fosphenytoin—Rash—Cyclosporine—psoriasis	7.73e-05	0.000282	CcSEcCtD
Fosphenytoin—Anorexia—Prednisone—psoriasis	7.73e-05	0.000282	CcSEcCtD
Fosphenytoin—Dermatitis—Cyclosporine—psoriasis	7.72e-05	0.000282	CcSEcCtD
Fosphenytoin—Pruritus—Hydrocortisone—psoriasis	7.71e-05	0.000281	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Methotrexate—psoriasis	7.7e-05	0.000281	CcSEcCtD
Fosphenytoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.68e-05	0.00431	CbGpPWpGaD
Fosphenytoin—Headache—Cyclosporine—psoriasis	7.68e-05	0.00028	CcSEcCtD
Fosphenytoin—Anaemia—Methotrexate—psoriasis	7.67e-05	0.00028	CcSEcCtD
Fosphenytoin—Feeling abnormal—Betamethasone—psoriasis	7.67e-05	0.00028	CcSEcCtD
Fosphenytoin—Feeling abnormal—Dexamethasone—psoriasis	7.67e-05	0.00028	CcSEcCtD
Fosphenytoin—Vomiting—Mycophenolate mofetil—psoriasis	7.6e-05	0.000277	CcSEcCtD
Fosphenytoin—Rash—Mycophenolate mofetil—psoriasis	7.54e-05	0.000275	CcSEcCtD
Fosphenytoin—Dermatitis—Mycophenolate mofetil—psoriasis	7.53e-05	0.000275	CcSEcCtD
Fosphenytoin—Headache—Mycophenolate mofetil—psoriasis	7.49e-05	0.000273	CcSEcCtD
Fosphenytoin—Malaise—Methotrexate—psoriasis	7.48e-05	0.000273	CcSEcCtD
Fosphenytoin—Vertigo—Methotrexate—psoriasis	7.46e-05	0.000272	CcSEcCtD
Fosphenytoin—Diarrhoea—Hydrocortisone—psoriasis	7.45e-05	0.000272	CcSEcCtD
Fosphenytoin—Leukopenia—Methotrexate—psoriasis	7.43e-05	0.000271	CcSEcCtD
Fosphenytoin—SCN5A—Developmental Biology—CARM1—psoriasis	7.43e-05	0.00417	CbGpPWpGaD
Fosphenytoin—Urticaria—Betamethasone—psoriasis	7.39e-05	0.00027	CcSEcCtD
Fosphenytoin—Urticaria—Dexamethasone—psoriasis	7.39e-05	0.00027	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Prednisone—psoriasis	7.38e-05	0.000269	CcSEcCtD
Fosphenytoin—Dizziness—Prednisolone—psoriasis	7.38e-05	0.000269	CcSEcCtD
Fosphenytoin—Asthenia—Triamcinolone—psoriasis	7.36e-05	0.000268	CcSEcCtD
Fosphenytoin—Body temperature increased—Betamethasone—psoriasis	7.36e-05	0.000268	CcSEcCtD
Fosphenytoin—Body temperature increased—Dexamethasone—psoriasis	7.36e-05	0.000268	CcSEcCtD
Fosphenytoin—Insomnia—Prednisone—psoriasis	7.33e-05	0.000267	CcSEcCtD
Fosphenytoin—Nausea—Cyclosporine—psoriasis	7.28e-05	0.000266	CcSEcCtD
Fosphenytoin—Paraesthesia—Prednisone—psoriasis	7.28e-05	0.000265	CcSEcCtD
Fosphenytoin—Pruritus—Triamcinolone—psoriasis	7.26e-05	0.000265	CcSEcCtD
Fosphenytoin—Cough—Methotrexate—psoriasis	7.24e-05	0.000264	CcSEcCtD
Fosphenytoin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	7.2e-05	0.00404	CbGpPWpGaD
Fosphenytoin—Dizziness—Hydrocortisone—psoriasis	7.2e-05	0.000263	CcSEcCtD
Fosphenytoin—Convulsion—Methotrexate—psoriasis	7.19e-05	0.000262	CcSEcCtD
Fosphenytoin—Dyspepsia—Prednisone—psoriasis	7.13e-05	0.00026	CcSEcCtD
Fosphenytoin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	7.1e-05	0.00399	CbGpPWpGaD
Fosphenytoin—Nausea—Mycophenolate mofetil—psoriasis	7.1e-05	0.000259	CcSEcCtD
Fosphenytoin—Arthralgia—Methotrexate—psoriasis	7.07e-05	0.000258	CcSEcCtD
Fosphenytoin—Myalgia—Methotrexate—psoriasis	7.07e-05	0.000258	CcSEcCtD
Fosphenytoin—Decreased appetite—Prednisone—psoriasis	7.05e-05	0.000257	CcSEcCtD
Fosphenytoin—Rash—Prednisolone—psoriasis	7.03e-05	0.000257	CcSEcCtD
Fosphenytoin—Dermatitis—Prednisolone—psoriasis	7.03e-05	0.000256	CcSEcCtD
Fosphenytoin—Headache—Prednisolone—psoriasis	6.99e-05	0.000255	CcSEcCtD
Fosphenytoin—Discomfort—Methotrexate—psoriasis	6.98e-05	0.000255	CcSEcCtD
Fosphenytoin—Constipation—Prednisone—psoriasis	6.93e-05	0.000253	CcSEcCtD
Fosphenytoin—Vomiting—Hydrocortisone—psoriasis	6.93e-05	0.000253	CcSEcCtD
Fosphenytoin—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	6.91e-05	0.00387	CbGpPWpGaD
Fosphenytoin—Rash—Hydrocortisone—psoriasis	6.87e-05	0.000251	CcSEcCtD
Fosphenytoin—Dermatitis—Hydrocortisone—psoriasis	6.86e-05	0.00025	CcSEcCtD
Fosphenytoin—ALB—Selenium Micronutrient Network—CAT—psoriasis	6.85e-05	0.00384	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—CRP—psoriasis	6.85e-05	0.00384	CbGpPWpGaD
Fosphenytoin—Confusional state—Methotrexate—psoriasis	6.83e-05	0.000249	CcSEcCtD
Fosphenytoin—Headache—Hydrocortisone—psoriasis	6.82e-05	0.000249	CcSEcCtD
Fosphenytoin—Dizziness—Triamcinolone—psoriasis	6.78e-05	0.000247	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Methotrexate—psoriasis	6.77e-05	0.000247	CcSEcCtD
Fosphenytoin—Infection—Methotrexate—psoriasis	6.73e-05	0.000245	CcSEcCtD
Fosphenytoin—Feeling abnormal—Prednisone—psoriasis	6.68e-05	0.000244	CcSEcCtD
Fosphenytoin—Asthenia—Betamethasone—psoriasis	6.68e-05	0.000244	CcSEcCtD
Fosphenytoin—Asthenia—Dexamethasone—psoriasis	6.68e-05	0.000244	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Methotrexate—psoriasis	6.63e-05	0.000242	CcSEcCtD
Fosphenytoin—Nausea—Prednisolone—psoriasis	6.63e-05	0.000242	CcSEcCtD
Fosphenytoin—Pruritus—Dexamethasone—psoriasis	6.58e-05	0.00024	CcSEcCtD
Fosphenytoin—Pruritus—Betamethasone—psoriasis	6.58e-05	0.00024	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Methotrexate—psoriasis	6.55e-05	0.000239	CcSEcCtD
Fosphenytoin—Vomiting—Triamcinolone—psoriasis	6.52e-05	0.000238	CcSEcCtD
Fosphenytoin—Nausea—Hydrocortisone—psoriasis	6.47e-05	0.000236	CcSEcCtD
Fosphenytoin—Rash—Triamcinolone—psoriasis	6.47e-05	0.000236	CcSEcCtD
Fosphenytoin—Dermatitis—Triamcinolone—psoriasis	6.46e-05	0.000236	CcSEcCtD
Fosphenytoin—Anorexia—Methotrexate—psoriasis	6.46e-05	0.000236	CcSEcCtD
Fosphenytoin—Urticaria—Prednisone—psoriasis	6.44e-05	0.000235	CcSEcCtD
Fosphenytoin—Headache—Triamcinolone—psoriasis	6.43e-05	0.000234	CcSEcCtD
Fosphenytoin—Body temperature increased—Prednisone—psoriasis	6.41e-05	0.000234	CcSEcCtD
Fosphenytoin—Diarrhoea—Betamethasone—psoriasis	6.37e-05	0.000232	CcSEcCtD
Fosphenytoin—Diarrhoea—Dexamethasone—psoriasis	6.37e-05	0.000232	CcSEcCtD
Fosphenytoin—Hypotension—Methotrexate—psoriasis	6.33e-05	0.000231	CcSEcCtD
Fosphenytoin—ALB—Folate Metabolism—ICAM1—psoriasis	6.29e-05	0.00353	CbGpPWpGaD
Fosphenytoin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.21e-05	0.00349	CbGpPWpGaD
Fosphenytoin—Musculoskeletal discomfort—Methotrexate—psoriasis	6.17e-05	0.000225	CcSEcCtD
Fosphenytoin—Dizziness—Dexamethasone—psoriasis	6.15e-05	0.000224	CcSEcCtD
Fosphenytoin—Dizziness—Betamethasone—psoriasis	6.15e-05	0.000224	CcSEcCtD
Fosphenytoin—Insomnia—Methotrexate—psoriasis	6.13e-05	0.000223	CcSEcCtD
Fosphenytoin—Nausea—Triamcinolone—psoriasis	6.09e-05	0.000222	CcSEcCtD
Fosphenytoin—Paraesthesia—Methotrexate—psoriasis	6.08e-05	0.000222	CcSEcCtD
Fosphenytoin—Dyspnoea—Methotrexate—psoriasis	6.04e-05	0.00022	CcSEcCtD
Fosphenytoin—Somnolence—Methotrexate—psoriasis	6.02e-05	0.00022	CcSEcCtD
Fosphenytoin—Dyspepsia—Methotrexate—psoriasis	5.96e-05	0.000217	CcSEcCtD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—CXCL8—psoriasis	5.93e-05	0.00333	CbGpPWpGaD
Fosphenytoin—Vomiting—Betamethasone—psoriasis	5.92e-05	0.000216	CcSEcCtD
Fosphenytoin—Vomiting—Dexamethasone—psoriasis	5.92e-05	0.000216	CcSEcCtD
Fosphenytoin—Decreased appetite—Methotrexate—psoriasis	5.89e-05	0.000215	CcSEcCtD
Fosphenytoin—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	5.89e-05	0.0033	CbGpPWpGaD
Fosphenytoin—Rash—Betamethasone—psoriasis	5.87e-05	0.000214	CcSEcCtD
Fosphenytoin—Rash—Dexamethasone—psoriasis	5.87e-05	0.000214	CcSEcCtD
Fosphenytoin—Dermatitis—Dexamethasone—psoriasis	5.86e-05	0.000214	CcSEcCtD
Fosphenytoin—Dermatitis—Betamethasone—psoriasis	5.86e-05	0.000214	CcSEcCtD
Fosphenytoin—Headache—Dexamethasone—psoriasis	5.83e-05	0.000213	CcSEcCtD
Fosphenytoin—Headache—Betamethasone—psoriasis	5.83e-05	0.000213	CcSEcCtD
Fosphenytoin—Asthenia—Prednisone—psoriasis	5.82e-05	0.000212	CcSEcCtD
Fosphenytoin—Pruritus—Prednisone—psoriasis	5.73e-05	0.000209	CcSEcCtD
Fosphenytoin—Feeling abnormal—Methotrexate—psoriasis	5.58e-05	0.000204	CcSEcCtD
Fosphenytoin—Diarrhoea—Prednisone—psoriasis	5.55e-05	0.000202	CcSEcCtD
Fosphenytoin—Nausea—Betamethasone—psoriasis	5.53e-05	0.000202	CcSEcCtD
Fosphenytoin—Nausea—Dexamethasone—psoriasis	5.53e-05	0.000202	CcSEcCtD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—JUN—psoriasis	5.52e-05	0.00309	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—CRP—psoriasis	5.44e-05	0.00305	CbGpPWpGaD
Fosphenytoin—Urticaria—Methotrexate—psoriasis	5.38e-05	0.000196	CcSEcCtD
Fosphenytoin—Dizziness—Prednisone—psoriasis	5.36e-05	0.000195	CcSEcCtD
Fosphenytoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.36e-05	0.003	CbGpPWpGaD
Fosphenytoin—Body temperature increased—Methotrexate—psoriasis	5.35e-05	0.000195	CcSEcCtD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—NFKB1—psoriasis	5.31e-05	0.00298	CbGpPWpGaD
Fosphenytoin—Vomiting—Prednisone—psoriasis	5.15e-05	0.000188	CcSEcCtD
Fosphenytoin—Rash—Prednisone—psoriasis	5.11e-05	0.000186	CcSEcCtD
Fosphenytoin—Dermatitis—Prednisone—psoriasis	5.11e-05	0.000186	CcSEcCtD
Fosphenytoin—Headache—Prednisone—psoriasis	5.08e-05	0.000185	CcSEcCtD
Fosphenytoin—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	5e-05	0.0028	CbGpPWpGaD
Fosphenytoin—ALB—SLC-mediated transmembrane transport—CP—psoriasis	4.91e-05	0.00275	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	4.9e-05	0.00275	CbGpPWpGaD
Fosphenytoin—Asthenia—Methotrexate—psoriasis	4.86e-05	0.000177	CcSEcCtD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.82e-05	0.0027	CbGpPWpGaD
Fosphenytoin—Nausea—Prednisone—psoriasis	4.81e-05	0.000176	CcSEcCtD
Fosphenytoin—Pruritus—Methotrexate—psoriasis	4.79e-05	0.000175	CcSEcCtD
Fosphenytoin—ALB—Folate Metabolism—IFNG—psoriasis	4.79e-05	0.00269	CbGpPWpGaD
Fosphenytoin—Diarrhoea—Methotrexate—psoriasis	4.63e-05	0.000169	CcSEcCtD
Fosphenytoin—Dizziness—Methotrexate—psoriasis	4.48e-05	0.000163	CcSEcCtD
Fosphenytoin—Vomiting—Methotrexate—psoriasis	4.31e-05	0.000157	CcSEcCtD
Fosphenytoin—Rash—Methotrexate—psoriasis	4.27e-05	0.000156	CcSEcCtD
Fosphenytoin—Dermatitis—Methotrexate—psoriasis	4.27e-05	0.000156	CcSEcCtD
Fosphenytoin—Headache—Methotrexate—psoriasis	4.24e-05	0.000155	CcSEcCtD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—TNF—psoriasis	4.13e-05	0.00232	CbGpPWpGaD
Fosphenytoin—Nausea—Methotrexate—psoriasis	4.02e-05	0.000147	CcSEcCtD
Fosphenytoin—ALB—Folate Metabolism—NFKB1—psoriasis	3.99e-05	0.00224	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.81e-05	0.00214	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.8e-05	0.00213	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—TYK2—psoriasis	3.8e-05	0.00213	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—LEP—psoriasis	3.55e-05	0.00199	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—IL6—psoriasis	3.33e-05	0.00187	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NDUFA5—psoriasis	3.19e-05	0.00179	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	3.17e-05	0.00178	CbGpPWpGaD
Fosphenytoin—ALB—Platelet degranulation—VEGFA—psoriasis	3.1e-05	0.00174	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—TNF—psoriasis	3.1e-05	0.00174	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—PPARG—psoriasis	3.09e-05	0.00173	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—IL6—psoriasis	3.07e-05	0.00172	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—ITGAL—psoriasis	2.98e-05	0.00167	CbGpPWpGaD
Fosphenytoin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.95e-05	0.00166	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—TP53—psoriasis	2.73e-05	0.00153	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYP2S1—psoriasis	2.71e-05	0.00152	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—TYK2—psoriasis	2.71e-05	0.00152	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NDUFA5—psoriasis	2.7e-05	0.00151	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—VEGFA—psoriasis	2.69e-05	0.00151	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NDUFA5—psoriasis	2.68e-05	0.00151	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.52e-05	0.00141	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.5e-05	0.0014	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—IL6—psoriasis	2.5e-05	0.0014	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—CP—psoriasis	2.49e-05	0.0014	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—TNF—psoriasis	2.46e-05	0.00138	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NDUFA5—psoriasis	2.41e-05	0.00135	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	2.38e-05	0.00133	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP2S1—psoriasis	2.3e-05	0.00129	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP2S1—psoriasis	2.28e-05	0.00128	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.25e-05	0.00126	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NDUFA5—psoriasis	2.2e-05	0.00123	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—NFKB1—psoriasis	2.11e-05	0.00118	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP2S1—psoriasis	2.05e-05	0.00115	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.05e-05	0.00115	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.99e-05	0.00111	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—VEGFA—psoriasis	1.92e-05	0.00107	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—STAT3—psoriasis	1.9e-05	0.00106	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP2S1—psoriasis	1.87e-05	0.00105	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—IL6—psoriasis	1.86e-05	0.00104	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—TNF—psoriasis	1.64e-05	0.000921	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NDUFA5—psoriasis	1.45e-05	0.000813	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.38e-05	0.000772	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—IL6—psoriasis	1.33e-05	0.000743	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CARM1—psoriasis	1.32e-05	0.000743	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP2S1—psoriasis	1.23e-05	0.000691	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—NOS2—psoriasis	1.22e-05	0.000687	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.2e-05	0.000675	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.2e-05	0.000671	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CARM1—psoriasis	1.12e-05	0.000629	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CARM1—psoriasis	1.11e-05	0.000625	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.07e-05	0.000602	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.05e-05	0.000588	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.04e-05	0.000584	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CARM1—psoriasis	1e-05	0.000561	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.79e-06	0.000549	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.35e-06	0.000525	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CARM1—psoriasis	9.12e-06	0.000512	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.53e-06	0.000478	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CAT—psoriasis	8.14e-06	0.000457	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—VEGFA—psoriasis	7.09e-06	0.000398	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CAT—psoriasis	6.89e-06	0.000387	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CAT—psoriasis	6.85e-06	0.000385	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—APOE—psoriasis	6.33e-06	0.000355	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CAT—psoriasis	6.15e-06	0.000345	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CARM1—psoriasis	6.02e-06	0.000337	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CAT—psoriasis	5.61e-06	0.000315	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PPARG—psoriasis	5.51e-06	0.000309	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TP53—psoriasis	5.36e-06	0.000301	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—APOE—psoriasis	5.36e-06	0.0003	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—APOE—psoriasis	5.33e-06	0.000299	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—APOE—psoriasis	4.78e-06	0.000268	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PPARG—psoriasis	4.67e-06	0.000262	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PPARG—psoriasis	4.64e-06	0.00026	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—APOE—psoriasis	4.36e-06	0.000245	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PPARG—psoriasis	4.16e-06	0.000234	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PPARG—psoriasis	3.8e-06	0.000213	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CAT—psoriasis	3.7e-06	0.000208	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—APOE—psoriasis	2.88e-06	0.000161	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PPARG—psoriasis	2.5e-06	0.00014	CbGpPWpGaD
